当前位置:首页 - 行情中心 - 精华制药(002349) - 财务分析 - 资产负债表

精华制药

(002349)

  

流通市值:62.61亿  总市值:62.77亿
流通股本:8.12亿   总股本:8.14亿

资产负债表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
流动资产:
货币资金921,758,780.31842,827,007.11751,208,813.22922,469,572.89
应收票据及应收账款298,787,887.7288,259,063.8316,701,738.88299,692,344.9
其中:应收票据49,922,425.3841,734,728.1546,535,252.0639,301,314.34
应收账款248,865,462.32246,524,335.65270,166,486.82260,391,030.56
应收款项融资88,884,200.5999,149,321.0779,879,290.6106,305,828.51
预付款项22,584,662.4615,515,207.8617,091,897.3424,386,419.85
其他应收款合计680,025.083,708,293.11,687,048.374,178,705.94
存货290,940,540.25303,364,221.74320,565,518.02315,483,984.74
一年内到期的非流动资产44,115,500-2,438,333.321,270,499.99
其他流动资产362,609.63485,948.11,741,731.641,127,729.63
流动资产平衡项目0000
流动资产合计1,985,809,222.461,861,912,528.531,793,751,316.591,800,443,905.63
非流动资产:
长期应收款-44,000,00044,000,00044,000,000
长期股权投资38,861,233.4339,501,932.7339,637,069.3140,004,953.76
其他权益工具投资1,158,339.224,950,0004,950,0004,950,000
投资性房地产257,169,095.2259,446,212.29261,723,329.33264,000,446.31
固定资产592,010,183605,233,517.07617,813,075.44628,842,933.12
在建工程69,423,079.0563,073,462.6863,728,495.8162,801,803.84
使用权资产1,928,330.82878,790.871,107,727.861,634,883.35
无形资产62,525,417.3963,206,831.7263,793,145.5864,417,167.85
商誉167,944,061.4167,944,061.4167,944,061.4167,944,061.4
递延所得税资产6,222,937.9812,568,568.3111,977,191.0511,970,007.85
其他非流动资产1,959,466944,871944,871944,871
非流动资产平衡项目0000
非流动资产合计1,199,202,143.491,261,748,248.071,277,618,966.781,291,511,128.48
资产平衡项目0000
资产总计3,185,011,365.953,123,660,776.63,071,370,283.373,091,955,034.11
流动负债:
短期借款20,924,506.6921,021,949.7310,008,637.521,024,805.54
应付票据及应付账款141,943,533.52158,557,194.11171,276,373.46143,955,185.87
其中:应付票据13,487,553.4825,702,493.1525,817,381.4419,383,314.97
应付账款128,455,980.04132,854,700.96145,458,992.02124,571,870.9
合同负债13,598,708.1717,286,822.414,954,223.8824,416,332.85
应付职工薪酬64,350,903.6353,969,180.5745,990,148.8249,750,716.72
应交税费26,996,486.7220,045,066.0922,295,427.0330,454,194.7
其他应付款合计77,089,230.8873,098,597.8674,522,502.372,228,963.45
一年内到期的非流动负债1,180,089.8436,130.61505,686.64680,308.46
其他流动负债15,426,055.562,414,317.391,645,311.982,570,781.41
流动负债平衡项目0000
流动负债合计361,509,514.97346,829,258.76341,198,311.61345,081,289
非流动负债:
租赁负债434,174.18369,329.43451,228.37504,790.9
递延收益10,746,753.029,699,149.1710,188,221.1610,352,150.61
递延所得税负债7,958,293.9412,136,054.2512,230,388.3111,878,549.48
其他非流动负债97,726.22104,674.22109,552.22117,535.22
非流动负债平衡项目0000
非流动负债合计19,236,947.3622,309,207.0722,979,390.0622,853,026.21
负债平衡项目0000
负债合计380,746,462.33369,138,465.83364,177,701.67367,934,315.21
所有者权益(或股东权益):
实收资本(或股本)814,180,908814,180,908814,180,908814,180,908
资本公积769,004,594.63905,923,399.69905,923,399.69905,923,399.69
其他综合收益-3,222,911.66---
专项储备4,129,524.084,863,698.184,112,612.93,683,879.5
盈余公积117,504,830.03100,975,384.39100,975,384.39100,975,384.39
未分配利润742,996,252.1707,214,105.28666,472,182.12664,670,651.48
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计2,444,593,197.182,533,157,495.542,491,664,487.12,489,434,223.06
少数股东权益359,671,706.44221,364,815.23215,528,094.6234,586,495.84
股东权益平衡项目0000
股东权益合计2,804,264,903.622,754,522,310.772,707,192,581.72,724,020,718.9
负债和股东权益合计3,185,011,365.953,123,660,776.63,071,370,283.373,091,955,034.11
公告日期2024-04-192023-10-302023-08-262023-04-29
审计意见(境内)标准无保留意见
TOP↑